retatrutide fat loss clinical trial New Phase 3 data just dropped 👀 Eli Lilly's reported average weight approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Comment “curious” and I'll send

Gizem clarified

instead of being a single GLP-1 receptor agonist like semaglutide, tirzepatide is a GLP-1/glucose insulinotropic peptide (GIP) dual agonist, which explains the greater weight loss it delivers

Diabetology and Metabolic Syndrome, 14 (1)

doi: 10.1016/S0140-6736(10)60307-8 34 NauckMFridAHermansenKShahNSTankovaTMithaIHet al

In particular, youll want to take note of how full your top and bottom lips are, how prominent your Cupids bow is, and whether your lips turn downward at the outer edges

SeekPeptides members access detailed macro calculators and protocol guides that account for these specific adjustments when combining dietary strategies with peptide therapy